The identification of predictive biomarkers typically involves clinical trials and longitudinal studies. Researchers collect and analyze biological samples from patients over time, looking for patterns that correlate with disease outcomes or treatment responses. Advanced techniques like genomics, proteomics, and bioinformatics are often employed to identify and validate these biomarkers.
